换一批
换一批Combined therapeutic potential of nuclear receptors with receptor tyrosine kinase inhibitors in lung cancer.
第一作者：
Peninah M,Wairagu
第一单位：
Department of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, Gangwon-do 220-701, Republic of Korea; Institute of Lifestyle Medicine, Wonju College of Medicine, Yonsei University, Wonju, Gangwon-do 220-701, Republic of Korea; Nuclear Receptor Research Consortium, Wonju College of Medicine, Yonsei University, Wonju, Gangwon-do 220-701, Republic of Korea.
作者：
主题词
抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞系, 肿瘤(Cell Line, Tumor);细胞周期蛋白B(Cyclin B);细胞周期蛋白D1(Cyclin D1);人类(Humans);烃类, 氟化(Hydrocarbons, Fluorinated);吲哚类(Indoles);肺肿瘤(Lung Neoplasms);孤儿核受体(Orphan Nuclear Receptors);蛋白激酶抑制剂(Protein Kinase Inhibitors);喹唑啉类(Quinazolines);受体, 胞质和核(Receptors, Cytoplasmic and Nuclear);磺胺类(Sulfonamides);砜类(Sulfones)
DOI
10.1016/j.bbrc.2014.04.018
PMID
24735536
发布时间
2022-03-11
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
